Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 196.1% in July

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Rating) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 460,800 shares, an increase of 196.1% from the June 30th total of 155,600 shares. Based on an average daily trading volume, of 1,267,400 shares, the short-interest ratio is currently 0.4 days.

Analyst Ratings Changes

Several research analysts have commented on BAYRY shares. Barclays lifted their price target on Bayer Aktiengesellschaft from €85.00 ($86.73) to €90.00 ($91.84) and gave the stock an “overweight” rating in a research report on Wednesday, May 11th. UBS Group lifted their price target on Bayer Aktiengesellschaft from €90.00 ($91.84) to €96.00 ($97.96) and gave the stock a “buy” rating in a research report on Thursday, May 19th. Finally, Morgan Stanley boosted their price objective on Bayer Aktiengesellschaft from €83.00 ($84.69) to €85.00 ($86.73) and gave the company an “overweight” rating in a research report on Wednesday, July 20th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.75.

Bayer Aktiengesellschaft Price Performance

Bayer Aktiengesellschaft stock opened at $14.62 on Thursday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.88 and a current ratio of 1.23. Bayer Aktiengesellschaft has a 52 week low of $12.45 and a 52 week high of $18.45. The firm has a market cap of $57.45 billion, a P/E ratio of 24.78, a P/E/G ratio of 1.45 and a beta of 1.14. The business’s fifty day moving average is $15.87 and its two-hundred day moving average is $15.89.

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Rating) last posted its quarterly earnings data on Tuesday, May 10th. The company reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.21. Bayer Aktiengesellschaft had a return on equity of 21.73% and a net margin of 4.29%. The business had revenue of $16.43 billion during the quarter, compared to the consensus estimate of $15.01 billion. Equities research analysts forecast that Bayer Aktiengesellschaft will post 1.97 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Cuts Dividend

The company also recently disclosed a dividend, which was paid on Monday, May 16th. Investors of record on Tuesday, May 3rd were issued a dividend of $0.3693 per share. This represents a dividend yield of 2.26%. The ex-dividend date was Monday, May 2nd. Bayer Aktiengesellschaft’s dividend payout ratio (DPR) is 59.32%.

About Bayer Aktiengesellschaft

(Get Rating)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

See Also

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.